Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Antibodies to Brewer's Yeast in Rheumatoid Arthritis.

Lichtenstein JR, Epstein AL.

Cureus. 2019 May 17;11(5):e4691. doi: 10.7759/cureus.4691.

2.

Generation of a Monoclonal Antibody to Detect Elastin-like Polypeptides.

Kouhi A, Yao Z, Zheng L, Li Z, Hu P, Epstein AL, MacKay JA.

Biomacromolecules. 2019 Aug 12;20(8):2942-2952. doi: 10.1021/acs.biomac.9b00503. Epub 2019 Jul 19.

PMID:
31276401
3.

Botulinum Neurotoxin Light Chains Expressed by Defective Herpes Simplex Virus Type-1 Vectors Cleave SNARE Proteins and Inhibit CGRP Release in Rat Sensory Neurons.

Joussain C, Le Coz O, Pichugin A, Marconi P, Lim F, Sicurella M, Salonia A, Montorsi F, Wandosell F, Foster K, Giuliano F, Epstein AL, Aranda Muñoz A.

Toxins (Basel). 2019 Feb 19;11(2). pii: E123. doi: 10.3390/toxins11020123.

4.

Costimulation of type-2 innate lymphoid cells by GITR promotes effector function and ameliorates type 2 diabetes.

Galle-Treger L, Sankaranarayanan I, Hurrell BP, Howard E, Lo R, Maazi H, Lewis G, Banie H, Epstein AL, Hu P, Rehan VK, Gilliland FD, Allayee H, Soroosh P, Sharpe AH, Akbari O.

Nat Commun. 2019 Feb 12;10(1):713. doi: 10.1038/s41467-019-08449-x.

5.

Histidine-Rich Glycoprotein Inhibits HIV-1 Infection in a pH-Dependent Manner.

Dantas E, Erra Díaz F, Pereyra Gerber P, Varese A, Jerusalinsky DA, Epstein AL, García Rivello HJ, Del Valle Jaén A, Pandolfi JB, Ceballos A, Ostrowski M, Sabatté J, Geffner J.

J Virol. 2019 Feb 5;93(4). pii: e01749-18. doi: 10.1128/JVI.01749-18. Print 2019 Feb 15.

6.

Construction and characterization of a new TRAIL soluble form, active at picomolar concentrations.

Melendez ME, Silva-Oliveira RJ, Silva Almeida Vicente AL, Rebolho Batista Arantes LM, Carolina de Carvalho A, Epstein AL, Reis RM, Carvalho AL.

Oncotarget. 2018 Jun 5;9(43):27233-27241. doi: 10.18632/oncotarget.25519. eCollection 2018 Jun 5.

7.

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.

Ng SY, Yoshida N, Christie AL, Ghandi M, Dharia NV, Dempster J, Murakami M, Shigemori K, Morrow SN, Van Scoyk A, Cordero NA, Stevenson KE, Puligandla M, Haas B, Lo C, Meyers R, Gao G, Cherniack A, Louissaint A Jr, Nardi V, Thorner AR, Long H, Qiu X, Morgan EA, Dorfman DM, Fiore D, Jang J, Epstein AL, Dogan A, Zhang Y, Horwitz SM, Jacobsen ED, Santiago S, Ren JG, Guerlavais V, Annis DA, Aivado M, Saleh MN, Mehta A, Tsherniak A, Root D, Vazquez F, Hahn WC, Inghirami G, Aster JC, Weinstock DM, Koch R.

Nat Commun. 2018 May 22;9(1):2024. doi: 10.1038/s41467-018-04356-9.

8.

IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.

Kadin ME, Morgan J, Xu H, Epstein AL, Sieber D, Hubbard BA, Adams WP Jr, Bacchi CE, Goes JCS, Clemens MW, Medeiros LJ, Miranda RN.

Hum Pathol. 2018 Aug;78:54-62. doi: 10.1016/j.humpath.2018.04.007. Epub 2018 Apr 22.

PMID:
29689246
9.

Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation.

Kumar P, Marinelarena A, Raghunathan D, Ragothaman VK, Saini S, Bhattacharya P, Fan J, Epstein AL, Maker AV, Prabhakar BS.

Cell Mol Immunol. 2019 Feb;16(2):138-153. doi: 10.1038/cmi.2018.8. Epub 2018 Mar 26.

PMID:
29578532
10.

Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti-Tumor Effects against B-Cell Lymphoma.

Zheng L, Hu P, Wolfe B, Gonsalves C, Ren L, Khawli LA, Kaslow HR, Epstein AL.

Int J Mol Sci. 2017 Dec 20;18(12). pii: E2773. doi: 10.3390/ijms18122773.

11.

PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells.

Alharshawi K, Marinelarena A, Kumar P, El-Sayed O, Bhattacharya P, Sun Z, Epstein AL, Maker AV, Prabhakar BS.

Sci Rep. 2017 Jul 26;7(1):6594. doi: 10.1038/s41598-017-05254-8.

12.

Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.

Chen J, Zhang Y, Petrus MN, Xiao W, Nicolae A, Raffeld M, Pittaluga S, Bamford RN, Nakagawa M, Ouyang ST, Epstein AL, Kadin ME, Del Mistro A, Woessner R, Jaffe ES, Waldmann TA.

Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3975-3980. doi: 10.1073/pnas.1700682114. Epub 2017 Mar 29.

13.

Soluble OX40L and JAG1 Induce Selective Proliferation of Functional Regulatory T-Cells Independent of canonical TCR signaling.

Kumar P, Alharshawi K, Bhattacharya P, Marinelarena A, Haddad C, Sun Z, Chiba S, Epstein AL, Prabhakar BS.

Sci Rep. 2017 Jan 3;7:39751. doi: 10.1038/srep39751.

14.

[Phosphorylation of repressive histone H3K9me3 is required for HSV-1 reactivation].

Epstein AL.

Med Sci (Paris). 2016 Dec;32(12):1065-1067. doi: 10.1051/medsci/20163212007. Epub 2017 Jan 3. French. No abstract available.

15.

Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins.

Smith A, Manoli H, Jaw S, Frutoz K, Epstein AL, Khawli LA, Theil FP.

J Immunol Res. 2016;2016:2342187. doi: 10.1155/2016/2342187. Epub 2016 Aug 8. Review.

16.

Age-dependent divergent effects of OX40L treatment on the development of diabetes in NOD mice.

Haddad CS, Bhattacharya P, Alharshawi K, Marinelarena A, Kumar P, El-Sayed O, Elshabrawy HA, Epstein AL, Prabhakar BS.

Autoimmunity. 2016 Aug;49(5):298-311. doi: 10.1080/08916934.2016.1183657. Epub 2016 May 31.

17.

Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Kadin ME, Deva A, Xu H, Morgan J, Khare P, MacLeod RA, Van Natta BW, Adams WP Jr, Brody GS, Epstein AL.

Aesthet Surg J. 2016 Jul;36(7):773-81. doi: 10.1093/asj/sjw023. Epub 2016 Mar 15.

PMID:
26979456
18.

Systemic delivery of chTNT-3/CpG immunoconjugates for immunotherapy in murine solid tumor models.

Jang JK, Khawli LA, Canter DC, Hu P, Zhu TH, Wu BW, Angell TE, Li Z, Epstein AL.

Cancer Immunol Immunother. 2016 May;65(5):511-23. doi: 10.1007/s00262-016-1813-x. Epub 2016 Mar 9.

19.

Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant.

Andersen BM, Xia J, Epstein AL, Ohlfest JR, Chen W, Blazar BR, Pennell CA, Olin MR.

J Immunother Cancer. 2016 Feb 16;4:11. doi: 10.1186/s40425-016-0112-6. eCollection 2016.

20.

Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent.

Angell TE, Lechner MG, Smith AM, Martin SE, Groshen SG, Maceri DR, Singer PA, Epstein AL.

Thyroid. 2016 Mar;26(3):381-9. doi: 10.1089/thy.2015.0289. Epub 2016 Feb 10.

21.

Phase 1 Dose-Escalation Study with LEC/chTNT-3 and Toceranib Phosphate (Palladia®) in Dogs with Spontaneous Malignancies.

Jang JK, Chretin J, Bruyette D, Hu P, Epstein AL.

J Cancer Sci Ther. 2015;7(6):167-174. Epub 2015 May 30.

22.

[Herpes simplex virus type 1 latency and reactivation: an update].

Aranda AM, Epstein AL.

Med Sci (Paris). 2015 May;31(5):506-14. doi: 10.1051/medsci/20153105012. Epub 2015 Jun 9. Review. French.

23.

Murine Bone Marrow-Derived Dendritic Cells Transduced by Light-Helper-Dependent Herpes Simplex Virus-1 Amplicon Vector Acquire a Mature Dendritic Cell Phenotype.

Oz-Arslan D, Tsitoura E, Kazazi D, Kouvatsis V, Epstein AL, Mavromara P.

Hum Gene Ther Methods. 2015 Jun;26(3):93-102. doi: 10.1089/hgtb.2015.042.

PMID:
26046494
24.

Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases.

Brody GS, Deapen D, Taylor CR, Pinter-Brown L, House-Lightner SR, Andersen JS, Carlson G, Lechner MG, Epstein AL.

Plast Reconstr Surg. 2015 Mar;135(3):695-705. doi: 10.1097/PRS.0000000000001033. Review. Erratum in: Plast Reconstr Surg. 2015 Aug;136(2):426.

PMID:
25490535
25.

Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors for gene transfer and gene therapy.

Fraefel C, Marconi P, Epstein AL.

Methods Mol Biol. 2015;1254:295-316. doi: 10.1007/978-1-4939-2152-2_21.

PMID:
25431073
26.

Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy.

Marconi P, Fraefel C, Epstein AL.

Methods Mol Biol. 2015;1254:269-93. doi: 10.1007/978-1-4939-2152-2_20.

PMID:
25431072
27.

Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors.

Gayral M, Lulka H, Hanoun N, Biollay C, Sèlves J, Vignolle-Vidoni A, Berthommé H, Trempat P, Epstein AL, Buscail L, Béjot JL, Cordelier P.

Hum Gene Ther. 2015 Feb;26(2):104-13. doi: 10.1089/hum.2014.072. Epub 2015 Jan 19.

28.

MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro.

Angell TE, Lechner MG, Jang JK, LoPresti JS, Epstein AL.

Clin Cancer Res. 2014 Dec 1;20(23):6034-44. doi: 10.1158/1078-0432.CCR-14-0879. Epub 2014 Oct 7.

29.

Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA.

Bryan RA, Jiang Z, Jandl T, Strauss J, Koba W, Onyedika C, Morgenstern A, Bruchertseifer F, Epstein AL, Dadachova E.

Expert Rev Anticancer Ther. 2014 Oct;14(10):1243-9. doi: 10.1586/14737140.2014.952285. Epub 2014 Aug 26.

PMID:
25156106
30.

BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration.

Angell TE, Lechner MG, Jang JK, Correa AJ, LoPresti JS, Epstein AL.

Thyroid. 2014 Sep;24(9):1385-93. doi: 10.1089/thy.2014.0134. Epub 2014 Jul 15.

31.

Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors.

Melendez ME, Fraefel C, Epstein AL.

Methods Mol Biol. 2014;1144:81-98. doi: 10.1007/978-1-4939-0428-0_6.

PMID:
24671678
32.

A hybrid protein-polymer nanoworm potentiates apoptosis better than a monoclonal antibody.

Aluri SR, Shi P, Gustafson JA, Wang W, Lin YA, Cui H, Liu S, Conti PS, Li Z, Hu P, Epstein AL, MacKay JA.

ACS Nano. 2014 Mar 25;8(3):2064-76. doi: 10.1021/nn403973g. Epub 2014 Feb 14.

33.

Boron neutron capture therapy as new treatment for clear cell sarcoma: trial on different animal model.

Andoh T, Fujimoto T, Sudo T, Suzuki M, Sakurai Y, Sakuma T, Moritake H, Sugimoto T, Takeuchi T, Sonobe H, Epstein AL, Fukumori Y, Ono K, Ichikawa H.

Appl Radiat Isot. 2014 Jun;88:59-63. doi: 10.1016/j.apradiso.2013.12.007. Epub 2013 Dec 17.

PMID:
24389062
34.

CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma.

Murphy KA, Erickson JR, Johnson CS, Seiler CE, Bedi J, Hu P, Pluhar GE, Epstein AL, Ohlfest JR.

J Immunol. 2014 Jan 1;192(1):224-33. doi: 10.4049/jimmunol.1301633. Epub 2013 Nov 29.

35.

Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy.

Lechner MG, Karimi SS, Barry-Holson K, Angell TE, Murphy KA, Church CH, Ohlfest JR, Hu P, Epstein AL.

J Immunother. 2013 Nov-Dec;36(9):477-89. doi: 10.1097/01.cji.0000436722.46675.4a.

36.

Cytoreductive chemotherapy improves the biodistribution of antibodies directed against tumor necrosis in murine solid tumor models.

Jang JK, Khawli LA, Park R, Wu BW, Li Z, Canter D, Conti PS, Epstein AL.

Mol Cancer Ther. 2013 Dec;12(12):2827-36. doi: 10.1158/1535-7163.MCT-13-0383. Epub 2013 Oct 15.

37.

Modulation of Treg cells/T effector function by GITR signaling is context-dependent.

Ephrem A, Epstein AL, Stephens GL, Thornton AM, Glass D, Shevach EM.

Eur J Immunol. 2013 Sep;43(9):2421-9. doi: 10.1002/eji.201343451. Epub 2013 Jul 3.

38.

Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma.

Russell S, Angell T, Lechner M, Liebertz D, Correa A, Sinha U, Kokot N, Epstein A.

Head Neck Oncol. 2013 Feb 27;5(3):24.

39.

Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.

Russell SM, Lechner MG, Mokashi A, Megiel C, Jang JK, Taylor CR, Looijenga LH, French CA, Epstein AL.

Urology. 2013 Feb;81(2):464.e1-9. doi: 10.1016/j.urology.2012.09.029.

40.

Generation of tumor-targeted antibody-CpG conjugates.

Li Z, Jang JK, Lechner MG, Hu P, Khawli L, Scannell CA, Epstein AL.

J Immunol Methods. 2013 Mar 29;389(1-2):45-51. doi: 10.1016/j.jim.2012.12.009. Epub 2012 Dec 29.

PMID:
23279945
41.

Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphoma.

Lechner MG, Megiel C, Church CH, Angell TE, Russell SM, Sevell RB, Jang JK, Brody GS, Epstein AL.

Clin Cancer Res. 2012 Sep 1;18(17):4549-59. doi: 10.1158/1078-0432.CCR-12-0101. Epub 2012 Jul 12.

42.

An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas.

Murphy KA, Lechner MG, Popescu FE, Bedi J, Decker SA, Hu P, Erickson JR, O'Sullivan MG, Swier L, Salazar AM, Olin MR, Epstein AL, Ohlfest JR.

Clin Cancer Res. 2012 Sep 1;18(17):4657-68. doi: 10.1158/1078-0432.CCR-12-0990. Epub 2012 Jul 10.

43.

Factors influencing helper-independent adeno-associated virus replication.

Nicolas A, Jolinon N, Alazard-Dany N, Barateau V, Epstein AL, Greco A, Büning H, Salvetti A.

Virology. 2012 Oct 10;432(1):1-9. doi: 10.1016/j.virol.2012.05.027. Epub 2012 Jun 22.

44.

HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice.

Laimbacher AS, Esteban LE, Castello AA, Abdusetir Cerfoglio JC, Argüelles MH, Glikmann G, D'Antuono A, Mattion N, Berois M, Arbiza J, Hilbe M, Schraner EM, Seyffert M, Dresch C, Epstein AL, Ackermann M, Fraefel C.

Mol Ther. 2012 Sep;20(9):1810-20. doi: 10.1038/mt.2012.108. Epub 2012 Jun 19.

45.

The perichromatin region of the plant cell nucleus is the area with the strongest co-localisation of snRNA and SR proteins.

Niedojadło J, Mikulski Z, Dełeńko K, Szmidt-Jaworska A, Smoliński DJ, Epstein AL.

Planta. 2012 Aug;236(2):715-26. doi: 10.1007/s00425-012-1640-z. Epub 2012 Apr 24.

46.

Unique approach for B lymphoma therapy.

Epstein AL.

Blood. 2012 Apr 19;119(16):3647-8. doi: 10.1182/blood-2012-02-409052. No abstract available.

47.

Induction of humoral responses to BHV-1 glycoprotein D expressed by HSV-1 amplicon vectors.

Blanc AM, Berois MB, Tomé LM, Epstein AL, Arbiza JR.

J Vet Sci. 2012 Mar;13(1):59-65.

48.

Exploring the Therapeutic Efficacy of Glioma Vaccines Based on Allo- and Syngeneic Antigens and Distinct Immunological Costimulation Activators.

Stathopoulos A, Pretto C, Devillers L, Pierre D, Hofman FM, Epstein AL, Farghadani H, Kruse CA, Jadus MR, Chen TC, Schijns VE.

J Clin Cell Immunol. 2012;Suppl 5:004.

49.

Nucleolin interacts with US11 protein of herpes simplex virus 1 and is involved in its trafficking.

Greco A, Arata L, Soler E, Gaume X, Couté Y, Hacot S, Callé A, Monier K, Epstein AL, Sanchez JC, Bouvet P, Diaz JJ.

J Virol. 2012 Feb;86(3):1449-57. doi: 10.1128/JVI.06194-11. Epub 2011 Nov 30.

50.

Herpes simplex virus type 1-based amplicon vectors for fundamental research in neurosciences and gene therapy of neurological diseases.

Jerusalinsky D, Baez MV, Epstein AL.

J Physiol Paris. 2012 Jan;106(1-2):2-11. doi: 10.1016/j.jphysparis.2011.11.003. Epub 2011 Nov 15. Review.

PMID:
22108428

Supplemental Content

Loading ...
Support Center